AMZN
Amazon.com, Inc.
AMZN has the edge over BARK overall, supported by lower modeled downside and stronger valuation.
BARK
BARK, Inc.
BARK trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
BARK Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Stable | |
| Unavailable |
BARK's cash flow is currently stable, but its revenue and profitability are under pressure. There isn't enough data to rate its balance sheet.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
BARK PE Valuation
BARK has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over BARK on the outlook, with more favorable revenue expectations.
BARK Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Decline | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect BARK's losses to shrink, with revenue declining.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over BARK on earnings quality, reporting a profit while its opponent remains loss making.
BARK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.92 | +$1.08 |
| Q2 2026 | -$3.69 | -$0.29 |
| Q1 2026 | -$4.57 | -$0.77 |
| Q4 2025 | -$3.60 | $0.00 |
| Q3 2025 | -$4.00 | -$0.60 |
| Q2 2025 | -$3.40 | +$0.60 |
| Q1 2025 | -$3.80 | +$0.40 |
| Q4 2024 | -$3.60 | +$1.80 |
BARK is still losing money, but far less than before: $2.92 per share over the past year, against $8.80 at its worst in early 2022.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over BARK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over BARK on profitability, with a higher operating margin.
BARK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $87.6M | -18% |
| Q2 2026 | $78.8M | -23% |
| Q1 2026 | $86.6M | -25% |
| Q4 2025 | $98.4M | -22% |
| Q3 2025 | $107M | -15% |
| Q2 2025 | $102.9M | -11% |
| Q1 2025 | $115.4M | -5% |
| Q4 2024 | $126.4M | +1.1% |
BARK's revenue has slid since its 2022 peak: $88M last quarter, down 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -5.9% | +4.1 points |
| Q2 2026 | 0.1% | +8.2 points |
| Q1 2026 | -14% | -8.3 points |
| Q4 2025 | -9.1% | +0.5 points |
| Q3 2025 | -10% | -5.4 points |
| Q2 2025 | -8.1% | +1 points |
| Q1 2025 | -5.7% | -0.4 points |
| Q4 2024 | -9.7% | +1.5 points |
BARK's operating margin was −5.9% last quarter, up 4.1 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
BARK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.6M | +$24.5M |
| Q2 2026 | -$3.7M | +$2.5M |
| Q1 2026 | -$2.1M | +$9.9M |
| Q4 2025 | $1.6M | +$3.5M |
| Q3 2025 | -$19.9M | -2163% |
| Q2 2025 | -$6.1M | -$5.9M |
| Q1 2025 | -$12M | -$8.8M |
| Q4 2024 | -$2M | -115% |
BARK has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over BARK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
BARK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.6% | +143K shares |
| 1 year | +4.6% | +390K shares |
| 3 years | +0.9% | +79.1K shares |
| 5 years | +0.9% | +77.3K shares |
BARK has 9M diluted shares, up 4.6% from a year ago, despite $2M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2M |
| Q2 2026 | $233,000 |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $1.8M |
| Q1 2025 | $10.5M |
| Q4 2024 | $2.8M |
BARK spent $2M buying back its own shares over the past year, down 85% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
BARK Net Leverage
BARK's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
BARK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 36.6 | Neutral |
BARK's weekly RSI is 47 (neutral) and its Stochastic is 37 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
BARK PE vs Consumer Cyclical Sector
BARK has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over BARK on trend strength, trading above more of its moving averages.
BARK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.27 | 10% above |
| 20 week MA | $9.25 | 1.5% below |
| 50 week MA | $11.1 | 18% below |
| 100 week MA | $17.5 | 48% below |
| 200 week MA | $22.1 | 59% below |
BARK has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 59% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over BARK on returns for 2026, with the stronger performance.
BARK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $248.0 | $370.0 | +49% |
| 2021 | $370.0 | $84.0 | -77% |
| 2022 | $84.0 | $28.4 | -66% |
| 2023 | $28.4 | $16.1 | -43% |
| 2024 | $16.1 | $37.4 | +132% |
| 2025 | $37.4 | $12.3 | -67% |
| 2026 YTD | $12.3 | $9.11 | -26% |
BARK's yearly returns have swung widely, from +132% in 2024 to −77% in 2021. It's down 26% so far in 2026.